Brainsway Ltd. - American Depositary Shares (BWAY) closed at $11.44 on October 16, 2026, down 3.2% from the previous close, on volume of 63,535 shares (30-day average 104,296).
Data as of October 16, 2026.
16-Oct-2026
BrainsWay Expands U.S. Coverage for SWIFT Deep TMS to Over 70 Million Lives
TipRanks (Tue, 13-Oct 7:59 AM ET)
BrainsWay Reports Rise in Favorable Accelerated Deep TMS Coverage to Over 70 Million Covered Lives
Globe Newswire (Tue, 13-Oct 7:30 AM ET)
Globe Newswire (Tue, 8-Sep 7:30 AM ET)
BrainsWay Deep TMS Study Shows 70% Reduction in Patients Experiencing Suicidal Ideation
Globe Newswire (Thu, 27-Aug 7:30 AM ET)
BrainsWay Reports Second Quarter 2026 Financial Results and Operational Highlights
Globe Newswire (Wed, 12-Aug 7:30 AM ET)
BrainsWay to Report Second Quarter 2026 Financial Results on August 12, 2026
Globe Newswire (Wed, 29-Jul 7:30 AM ET)
BrainsWay Announces Strategic Investment in Radial Health, Inc.
Globe Newswire (Mon, 20-Jul 7:30 AM ET)
Market Chameleon (Mon, 12-Jan 3:44 AM ET)
BrainsWay’s Deep TMS Gains Broader Adolescent Depression Coverage as Optum Expands Policy
Market Chameleon (Mon, 22-Dec 5:15 AM ET)
BrainsWay Raises Full-Year Outlook After Reporting 29% Revenue Growth and 137% Jump in Profit
Market Chameleon (Tue, 11-Nov 4:15 AM ET)
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
Brainsway Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol BWAY.
As of October 16, 2026, BWAY stock price declined to $11.44 with 63,535 million shares trading.
BWAY has a beta of 0.79, meaning it tends to be less sensitive to market movements. BWAY has a correlation of 0.01 to the broad based SPY ETF.
BWAY has a market cap of $460.35 million. This is considered a Small Cap stock.
Last quarter Brainsway Ltd. - American Depositary Shares reported $17 million in Revenue and $.07 earnings per share. This beat revenue expectation by $610,200 and missed earnings estimates by -$.01.
In the last 3 years, BWAY traded as high as $17.40 and as low as $.77.
The top ETF exchange traded funds that BWAY belongs to (by Net Assets): IZRL, ITEQ, APIE, EHLS, IBRN.
BWAY has outperformed the market in the last year with a return of +186.0%, while the SPY ETF gained +16.7%. However, in the most recent history, BWAY shares have underperformed the stock market with its stock returning -22.9% in the last 3 month period and -8.5% for the last 2 week period, while SPY has returned +1.9% and -0.8%, respectively.
BWAY support price is $11.43 and resistance is $12.21 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BWAY shares will trade within this expected range on the day.
